What is the main business of Przedsiębiorstwo Farmaceutyczne Apexim?

The main business activity of Przedsiębiorstwo Farmaceutyczne Apexim focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 13, 2002.

Where is the headquarters located?

The headquarters is located at: Kinga C. Gillette 11, 94-406 Łódź.

Who is on the management board?

The management board includes: Bożena Helena Szymańska (President of the Management Board) and Katarzyna Nockowska Stańczak (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 77,700,000 (approx. $21 million).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of $40,173,522, representing an increase of 22.8% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $4,815,740, meaning the company increased its profit by 93.4%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $28,038,887 in 2025, representing 80% of all operating expenses.

Przedsiębiorstwo Farmaceutyczne ApeximS.A.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-02-13

Share capital

77 700 000,00 PLN

Activity description

Przedsiębiorstwo Farmaceutyczne Apexim S.A. is a pharmaceutical company based in Łódź at ul. Kinga C. Gillette 11. The excerpt lists the company’s registration details, including KRS 89677, NIP 896-11-71-623, and share capital of PLN 77,700,000, fully paid up.

Registered address

Kinga C. Gillette 11, 94-406 Łódź, Poland

Website

apexim-sa.pl

Electronic delivery address

AE:PL-56172-52355-VFRJF-19

Financials

Revenue history (in m)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 40.17mMedianUSD 1.76mAverageUSD 4.96m

Net profit

This companyUSD 4.82mMedianUSD 17.49kAverageUSD 77.31k

Operating costs

This companyUSD 34.89mMedianUSD 1.72mAverageUSD 4.80m

Assets

This companyUSD 33.88mMedianUSD 495.60kAverageUSD 1.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2003-12-31. Active

ING Bank Śląski
50 1050 0086 1000 0090 8117 7231
ING Bank Śląski
64 1050 0086 1000 0023 2584 7883
ING Bank Śląski
74 1050 0086 1000 0023 2584 7800

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Aleksandra Olszacka — Vice President of the Management Board

Bożena Helena Szymańska — President of the Management Board

Katarzyna Nockowska Stańczak — Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required for the validity of declarations made on behalf of the company.

Supervisory board

Andrzej Gawryś — Supervisory Board Member

Ewa Wasiak Zasada — Supervisory Board Member

Jarosław Piotr Strzecha — Supervisory Board Member

Ownership

Owner	Shares	Share value	Stake
DOZ S.A.	77,700,000	$20,988,654.78	100%

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki
Jacek Romuald Szwajcowski (62)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki

Subsidiaries

Name	Share value	Stake
Orion Tradingsp. z o.o.	2,001,620.75 USD	76%
Ardea Polskasp. z o.o.	42,679.63 USD	75.9615%
Apteka Jfmsp. z o.o.	11,075.09 USD	75.9259%

Competitors

Name	Revenue	Website
Przedsiębiorstwo Produkcyjno-Handlowe Apimexsp. z o.o.	$16,601,428.28	apimex.pl
APIS Farmacjasp. z o.o.	$14,614,704.02	apisapteka.pl
Farmjugsp. z o.o.	$14,506,326.49	farmjug.pl
Farmjug Agsp. z o.o.	$4,213,734.86	farmjug.pl
Adpharmasp. z o.o.	$4,026,799.19	adamed.com

Change history

Date	Event
2018-05-17	Share capital change (50,700,000.00 PLN → 77,700,000.00 PLN)
2014-09-12	Address change (Zbąszyńska 3, 91-342, Łódź → Kinga C. Gillette 11, 94-406, Łódź)
2008-08-25	Address change (Muchoborska 6, 54-424, Wrocław → Zbąszyńska 3, 91-342, Łódź)
2008-05-29	Share capital change (30,000,000.00 PLN → 50,700,000.00 PLN)
2007-06-27	Share capital change (10,454,694.00 PLN → 30,000,000.00 PLN)

FAQ

Last updated: 2026-06-09